The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1

Journal of Medicinal Chemistry

Volumn 53, Issue 5, 2010, Pages 2063-2075

  Fillion, Dany ^a   Lemieux, Guillaume ^a   Basambombo, Luta Luse ^a   Lavigne, Pierre ^a   Guillemette, Gaétan ^a   Leduc, Richard ^a   Escher, Emanuel ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZOYLPHENYLALANINE; 4 [3 (TRIFLUOROMETHYL) 3H DIAZIRIN 3 YL]PHENYLALANINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; IODINE 125; PHENYLALANINE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; DEGLYCOSYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROPHILICITY; PHOTOAFFINITY LABELING; PHOTOREACTIVITY; PROTEIN BINDING; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION;

EID: 77949417476     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm9015747     Document Type: Article

References (72)

1. Pierce, K. L.; Premont, R. T.; Lefkowitz, R. J. Seven-transmembrane receptors. Nat. Rev. Mol Cell Biol. 2002, 3, 639-650.
2. Bockaert, J.; Pin, J. P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. Embo J. 1999, 18,1723-1729.
3. Fredriksson, R.; Lagerstrom, M. C.; Lundin, L. G.; Schioth, H. B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol. 2003, 63, 1256-1272.
4. Kobilka, B. K. G protein coupled receptor structure and activation. Biochim. Biophys. Acta 2007, 1768, 794-807.
5. Gether, U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 2000, 21, 90-113.
6. Ji, T. H.; Grossmann, M.; Ji, I. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J. Biol. Chem. 1998, 273, 17299-17302.
7. Vodovozova, E. L. Photoaffinity labeling and its application in structural biology. Biochemistry (Mose.) 2007, 72, 1-20.
8. Hatanaka, Y.; Sadakane, Y. Photoaffinity labeling in drug discovery and developments: chemical gateway for entering proteomic frontier. Curr. Top. Med. Chem. 2002, 2, 271-288.
9. Dorman, G.; Prestwich, G. D. Using photolabile ligands in drug discovery and development. Trends Biotechnol 2000, 18, 64-77.
10. Dorman, G. Photoaffinity labeling in biological signal transduction. Top. Curr. Chem. 2000, 211, 169-225.
11. de Gasparo, M.; Catt, K. J.; Inagami, T.; Wright, J. W.; Unger, T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol. Rev. 2000, 52, 415-472.
12. Laporte, S. A.; Boucard, A. A.; Servant, G.; Guillemette, G.; Leduc, R.; Escher, E. Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II Mol Endocrinol. 1999, 13, 578-586.
13. Boucard, A. A.; Wilkes, B. C.; Laporte, S. A.; Escher, E.; Guillemette, G.; Leduc, R. Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptorbound angiotensin II adopts an extended structure. Biochemistry 2000, 39, 9662-9670.
14. Clement, M.; Martin, S. S.; Beaulieu, M. E.; Chamberland, C.; Lavigne, P.; Leduc, R.; Guillemette, G.; Escher, E. Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay. J. Biol. Chem. 2005, 280, 27121-27129.
15. Perodin, J.; Deraet, M.; Auger-Messier, M.; Boucard, A. A.; Rihakova, L.; Beaulieu, M. E.; Lavigne, P.; Parent, J. L.; Guillemette, G.; Leduc, R.; Escher, E. Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor. Biochemistry 2002, 41, 14348-14356.
16. Clement, M.; Cabana, J.; Holleran, B. J.; Leduc, R.; Guillemette, G.; Lavigne, P.; Escher, E. Activation induces structural changes in the liganded angiotensin II type 1 receptor. J. Biol. Chem. 2009, 284, 26603-26612.
17. Tzakos, A. G.; Gerothanassis, I. P.; Troganis, A. N. On the structural basis of the hypertensive properties of angiotensin II: a solved mystery or a controversial issue? Curr. Top. Med. Chem. 2004, 4, 431-444.
18. Peach, M. J. Structural features of angiotensin II which are important for biologic activity. Kidney Int. Suppl 1979, S3-6.
19. Regoli, D.; Park, W. K.; Rioux, F. Pharmacology of angiotensin. Pharmacol. Rev. 1974, 26, 69-123.
20. Khosla, M.; Smeby, R.; Bumpus, F. Structure activity relationship in angiotensin II analogs, In Handbook of Experimental Pharmacology; Springer: New York-Heidelberg-Berlin, 1974; Vol XXXVII, pp 126-156.
21. Feng, Y. H.; Miura, S.; Husain, A.; Karnik, S. S. Mechanism of constitutive activation of the ATI receptor: influence of the size of the agonist switch binding residue Asn(111). Biochemistry 1998, 37, 15791-15798.
22. Noda, K.; Feng, Y. H.; Liu, X. P.; Saad, Y.; Husain, A.; Karnik, S. S. The active state of the ATI angiotensin receptor is generated by angiotensin II induction. Biochemistry 1996, 35, 16435-16442.
23. Fillion, D.; Deraet, M.; Holleran, B. J.; Escher, E. Stereospecific synthesis of a carbene-generating angiotensin II analogue for comparative photoaffinity labeling: improved incorporation and absence of methionine selectivity. J. Med. Chem. 2006, 49, 2200-2209.
24. Bosse, R.; Servant, G.; Zhou, L. M.; Boulay, G.; Guillemette, G.; Escher, E. Sarl-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor. Regul Pept. 1993, 44, 215-223.
25. Lanctot, P. M.; Leclerc, P. C.; Clement, M.; Auger-Messier, M.; Escher, E.; Leduc, R.; Guillemette, G. Importance of N-glycosylation positioning for cell-surface expression, targeting, affinity and quality control of the human ATI receptor. Biochem. J. 2005, 390, 367-376.
26. Laporte, S. A.; Servant, G.; Richard, D. E.; Escher, E.; Guillemette, G.; Leduc, R. The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization. Mol Pharmacol. 1996, 49, 89-95.
27. Bayer, E. A.; Ben-Hur, H.; Wilchek, M. Analysis of proteins and glycoproteins on blots. Methods Enzymol 1990, 184, 415-427.
28. Durchschlag, H.; Christl, R.; Jaenicke, R. Progress in Colloid and Polymer Science; Springer: Berlin/Heidelberg, 1991; Vol 86, pp 41-56.
29. Fyhrquist, F.; Saijonmaa, O. Renin-angiotensin system revisited. J Intern. Med. 2008, 264, 224-236.
30. Pires, J. M.; Moore, G. J. Angiotensin charge relay system: role of arginine. Proc. West Pharmacol. Soc. 1998, 41, 197-199.
31. Wilkes, B. C.; Masaro, L.; Schiller, P. W.; Carpenter, K. A. Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments. J. Med. Chem. 2002, 45, 4410-4418.
32. Matsoukas, J. M.; Polevaya, L.; Ancans, J.; Mavromoustakos, T.; Kolocouris, A.; Roumelioti, P.; Vlahakos, D. V.; Yamdagni, R.; Wu, Q.; Moore, G. J. The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II. Bioorg. Med. Chem. 2000, 8, 1-10.
33. Miura, S.; Feng, Y. H.; Husain, A.; Karnik, S. S. Role of aromaticky of agonist switches of angiotensin II in the activation of the ATI receptor. J. Biol. Chem. 1999, 274, 7103-7110.
34. Tofovic, S. P.; Jackson, E. K. Tachyphylaxis to angiotensin II and [Phe4]-angiotensin II in the rat mesentery in vivo. J. Pharmacol. Exp. Ther. 1996, 276, 13-20.
35. Moore, G. J.; Ganter, R. C.; Matsoukas, J. M.; Hondrelis, J.; Agelis, G.; Barios, K.; Wilkinson, S.; Sandall, J.; Fowler, P. Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole. J. Mol. Recognit. 1994, 7, 251-256.
36. Guillemette, G.; Bernier, M.; Parent, P.; Leduc, R.; Escher, E. Angiotensin II: dependence of hormone affinity on the electronegativity of a single side chain. J. Med. Chem. 1984, 27, 315-320.
37. Aumelas, A.; Sakarellos, C.; Lintner, K.; Fermandjian, S.; Khosla, M. C.; Smeby, R. R.; Bumpus, F. M. Studies on angiotensin II and analogs: impact of substitution in position 8 on conformation and activity. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 1881-1885.
38. Clement, M.; Chamberland, C.; Perodin, J.; Leduc, R.; Guillemette, G.; Escher, E. The active and the inactive form of the hAT1 receptor have an identical ligand-binding environment: an MPA study on a constitutively active angiotensin II receptor mutant. J. Recept. Signal Transduct. Res. 2006, 26, 417-433.
39. Santos, E. L.; Pesquero, J. B.; Oliveira, L.; Paiva, A. C.; Costa-Neto, C. M. Mutagenesis of the ATI receptor reveals different binding modes of angiotensin II and [Sarl]-angiotensin II. Regul. Pept. 2004, 119, 183-188.
40. Hjorth, S. A.; Schambye, H. T.; Greenlee, W. J.; Schwartz, T. W. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. J. Biol. Chem. 1994, 269, 30953-30959.
41. Nicastro, G.; Peri, F.; Franzoni, L.; de Chiara, C.; Sartor, G.; Spisni, A. Conformational features of a synthetic model of the first extracellular loop of the angiotensin II AT1A receptor. J. Pept. Sci. 2003, 9, 229-243.
42. Salinas, R. K.; Shida, C. S.; Pertinhez, T. A.; Spisni, A.; Nakaie, C. R.; Paiva, A. C.; Schreier, S. Trifluoroethanol and binding to model membranes stabilize a predicted turn in a peptide corresponding to the first extracellular loop of the angiotensin II AT(1A) receptor. Biopolymers 2002, 65, 21-31.
43. Klco, J. M.; Nikiforovich, G. V.; Baranski, T. J. Genetic analysis of the first and third extracellular loops of the C5a receptor reveals an essential WXFG motif in the first loop. J. Biol. Chem. 2006, 281, 12010-12019.
44. Baleanu-Gogonea, C.; Karnik, S. Model of the whole rat ATI receptor and the ligand-binding site. J. Mol Model. 2006, 12, 325-337.
45. Hoe, K. L.; Saavedra, J. M. Site-directed mutagenesis of the gerbil and human angiotensin II AT(1) receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan. Mol Pharmacol. 2002, 61, 1404-1415.
46. Correa, S. A.; Zalcberg, H.; Han, S. W.; Oliveira, L.; Costa-Neto, CM.; Paiva, A. C.; Shimuta, S. I. Aliphatic amino acids in helix VI of the AT(I) receptor play a relevant role in agonist binding and activity. Regul. Pept. 2002, 106, 33-38.
47. Correa, S. A.; Franca, L. P.; Costa-Neto, C. M.; Oliveira, L.; Paiva, A. C.; Shimuta, S. I. Relevant role of Leu265 in helix VI of the angiotensin ATI receptor in agonist binding and activity. Can. J. Physiol. Pharmacol. 2002, 80, 426-430.
48. Gosselin, M. J.; Leclerc, P. C.; Auger-Messier, M.; Guillemette, G.; Escher, E.; Leduc, R. Molecular cloning of a ferret angiotensin II AT(1) receptor reveals the importance of position 163 for Losartan binding. Biochim. Biophys. Acta 2000, 1497, 94-102.
49. Costa-Neto, C. M.; Miyakawa, A. A.; Oliveira, L.; Hjorth, S. A.; Schwartz, T. W.; Paiva, A. C. Mutational analysis of the interaction of the N- and C-terminal ends of angiotensin II with the rat AT(1A) receptor. Br. J. Pharmacol. 2000, 130, 1263-1268.
50. Inoue, Y.; Nakamura, N.; Inagami, T. A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J. Hypertens. 1997, 15, 703-714.
51. Tate, J. J.; Persinger, J.; Bartholomew, B. Survey of four different photoreactive moieties for DNA photoaffinity labeling of yeast RNA polymerase III transcription complexes. Nucleic Acids Res. 1998, 25, 1421-1426.
52. Deseke, E.; Nakatami, Y.; Ourisson, G. Intrinsic reactivities of amino acids toward photoalkylation with benzophenone - a study preliminary to photolabelling of the transmembrane protein glycophorin A. Eur. J. Org. Chem. 1998, 243-251.
53. Weber, P. J.; Beck-Sickinger, A. G. Comparison of the photochemical behavior of four different photoactivatable probes. J. Pept. Res. 1997, 49, 375-383.
54. Fleming, S. A. Chemical reagents in photoaffinity labeling. Tetrahedron 1995, 51, 12479-12520.
55. Cherezov, V.; Rosenbaum, D. M.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Kuhn, P.; Weis, W. I.; Kobilka, B. K.; Stevens, R. C. High-resolution crystal structure of an engineered human beta2-adrenergic G proteincoupled receptor. Science 2007, 318, 1258-1265.
56. Park, J. H.; Scheerer, P.; Hofmann, K. P.; Choe, H. W.; Ernst, O. P. Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 2008, 454, 183-187.
57. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Le Trong, I.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
58. Ahuja, S.; Hornak, V.; Yan, E. C.; Syrett, N.; Goncalves, J. A.; Hirshfeld, A.; Ziliox, M.; Sakmar, T. P.; Sheves, M.; Reeves, P. J.; Smith, S. O.; Eilers, M. Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation. Nat. Struct. Mol Biol. 2009, 16, 168-175.
59. Shi, L.; Javitch, J. A. The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 440-445.
60. Shi, L.; Javitch, J. A. The binding site of aminergic G proteincoupled receptors: the transmembrane segments and second extracellular loop. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 437-467.
61. Warne, T.; Serrano-Vega, M. J.; Baker, J. G.; Moukhametzianov, R.; Edwards, P. C.; Henderson, R.; Leslie, A. G.; Tate, C. G.; Schertler, G. F. Structure of a betal-adrenergic G-protein-coupled receptor. Nature 2008, 454, 486-491.
62. Rasmussen, S. G.; Choi, H. J.; Rosenbaum, D. M.; Kobilka, T. S.; Thian, F. S.; Edwards, P. C.; Burghammer, M.; Ratnala, V. R.; Sanishvili, R.; Fischetti, R. F.; Schertler, G. F.; Weis, W. I.; Kobilka, B. K. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450, 383-387.
63. Fillion, D.; Guillemette, G.; Leduc, R.; Escher, E. In Agonist Activation of the Angiotensin II Type 1 Receptor Alters the Spatial Proximity of Transmembrane Domain 7 to the Ligand Binding Pocket, 19th American Peptide Society Symposium - Understanding Biology Using Peptides, San Diego, CA, USA, 2005, Blondelle, S. E., Ed.; American Peptide Society: San Diego, 2005; pp 357-358.
64. Fillion, D.; Guillemette, G.; Leduc, R.; Escher, E. Photoprobe peptides to map the interactions of angiotensin II with its receptor ATI. Adv. Exp. Med. Biol. 2009, 611, 329-330.
65. Rihakova, L.; Deraet, M.; Auger-Messier, M.; Perodin, J.; Boucard, A. A.; Guillemette, G.; Leduc, R.; Lavigne, P.; Escher, E. Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction. J. Recept. Signal Transduct. Res. 2002, 22, 297-313.
66. Ballesteros, J. A.; Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors; Academic Press: San Diego, CA, 1995; pp 366-428.
67. Fraker, P. J.; Speck, J. C., Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro3a, 6a-diphrenylglycoluril. Biochem. Biophys. Res. Commun. 1978, 80, 849-857.
68. Wiener, H. L.; Reith, M. E. Determination of radioligand specific activity using competition binding assays. Anal. Biochem. 1992, 207, 58-62.
69. Wiener, H. L.; Reith, M. E. Unknown radioligand specific activity. Trends Pharmacol. Sci. 1993, 14, 294-296.
70. Sambrook, J.; Russell, D. W. Molecular Cloning: A Laboratory Manual; Cold Spring Harbor Laboratory Press, 2001; Vol 3, pp A8.40-A48.51.
71. Schagger, H.; von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166, 368-379.
72. Schagger, H. Tricine-SDS-PAGE. Nat. Protoc. 2006, 1, 16-22.